| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |